SIC
NEPH icon

Salem Investment Counselors’s Nephros NEPH Stock Holding History

Salem Investment Counselors’s Portfolio NEPH Stock Details NEPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,500
Closed -$31K – 1098
2021
Q3 		$31K Hold
3,500
– – ﹤0.01% 570
2021
Q2 		$36K Hold
3,500
– – ﹤0.01% 536
2021
Q1 		$23K Buy
+3,500
New +$27.6K ﹤0.01% 571

Other funds holding NEPH

CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
SC
Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EP
Elkhorn Partners Omaha, Nebraska $157M AUM 11.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Salem Investment Counselors's NEPH Position: Q4 2021 in Review

Salem Investment Counselors sold out of Nephros (NEPH) in Q4 2021, closing a stake of 3,500 shares — an estimated $31K sold.

Salem Investment Counselors first reported a position in NEPH in Q1 2021 and held it in 3 quarters. The position peaked at $36K in Q2 2021. 17 funds tracked by Wall St. Rank hold NEPH as of Q4 2021.

  • Salem Investment Counselors reported no remaining Nephros position as of Q4 2021 after selling out during the quarter.
  • Salem Investment Counselors sold 3,500 Nephros shares in Q4 2021, an estimated $31K.
  • Salem Investment Counselors first reported a position in Nephros in Q1 2021 and held it in 3 quarters.
  • Salem Investment Counselors's Nephros position peaked at $36K in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Nephros as of Q4 2021.

Based on Salem Investment Counselors's 13F filing for Q4 2021, filed 15 Feb 2022.